Bortezomib-bendamustine-melphalan vs Melphalan for Multiple Myeloma

Clinical trial NCT06245629 · RECRUITING

Trial details

NCT number: NCT06245629
Sponsor: Uppsala University
Status: RECRUITING
Study type: OBSERVATIONAL

Myeloma Multiple

Start date: 2024-11-24
Primary completion: 2025-03-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.